Skip to main content
SpringerLink
Log in

Harnblasenkarzinom

  • Chapter
Therapiekonzepte Onkologie

  • 30 Accesses

Zusammenfassung

Weitere ätiologisch bedeutsame Faktoren sind der Zusammenhang zwischen Zigarettenkonsum und erhöhter Blasentumorinzidenz. Das relative Risiko beträgt im Verhältnis Raucher zu Nichtraucher 2:1 bis 6:1. Chronische Infekte spielen ebenfalls hier insbesondere in der Entstehung von Plattenepithelkarzinomen eine bedeutsame Rolle. Als ätiologische Faktoren sind hervorzuheben unspezifische chronische Harnwegsinfekte in Verbindung mit Steinleiden und Fremdkörpern, Bilharziose mit Organmanifestation in der Harnblase, die Balkannephropathie sowie die chronische interstitielle Nephritis. Gefährdete Berufsgruppen: Arbeiter in der Farbindustrie, gummiverarbeitenden Industrie, Gasproduktion in der Kohleindustrie, Kammerjäger, Aluminiumindustrie, Textilfärbung, Textilindustrie, Druckindustrie, Kriminomaler, Friseure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bloom HJG, Hendry WF, Wallace DM (1982) Treatment of T3 bladder cancer: controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review. But J Urol 54: 136

    Google Scholar 

  2. Boccardo F, Giuliani L et al (1992) Prophylaxis of superficial bladder carcinoma with MMC or rh-Interferon alpha 2b. Preliminary results of a multicentric Italian study. European Urology (Abstract) 282: 162

    Google Scholar 

  3. Bredael JJ, Croker BP, Glenn DF (1980) The curability of invasive bladder cancer treated by radical cystectomy. Eur Urol 6: 206

    PubMed  CAS  Google Scholar 

  4. Brendler CB, Schlegel PN, Walsh PC (1990) Urethrectomy with preservation of potency. J Urol 144: 270

    PubMed  CAS  Google Scholar 

  5. Debruyne FJG, van der Meyden PM (1987) BCG versus mitomycin C intravesical therapy in patients with superficial bladder cancer: First results of a randomized prospective trial. J Urol 137: 179A

    Google Scholar 

  6. Eberle J, Wohlgemut M, Bartsch G (1993) Results of combined radio-and chemotherapy for invasive bladder cancer. in press

    Google Scholar 

  7. Huland E, Huland H (1989) Local continuous high dose interleukin 2: A new therapeutic model for the treatment of advanced bladder carcinoma. Cancer Res 49: 5469

    Google Scholar 

  8. Khandekar JD, Elson PJ, de Wys WD, Slayton RE, Harris DT (1985) Comparative activity and toxicity of cis-diamminedichloroplatinum ( DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinoma of the urinary tract. J Clin Oncol 3: 539

    Google Scholar 

  9. Loehrer PJ, Elson P, Kuebler JP, Crawford ED, Tannock I, Raghavan D, Stuart-Harris R, Trump D, Einhorn LH (1990) Advanced bladder cancer: A prospective intergroup trial corn-paring single agent cisplatin (CDDP) vs M-VAC combination therapy (INT 0078) ( Meeting abstract ). Proc Am Soc Clin Oncol 9: A511

    Google Scholar 

  10. Logothetis CJ, Dexeus FH, Fin L, Sella A, Amato RJ, Ayala AG, Kilbourn RG (1990) A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol 8: 1050

    PubMed  CAS  Google Scholar 

  11. Logothetis CJ, Hossan B, Sella A, Dexeus FH, Amato RJ (1991) Fluorouracil and recombinant human interferon alpha-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors. J Natl Cancer Inst, 33, 4: 285

    Article  Google Scholar 

  12. Malkowicz SB, Nichols P, Lieskovsky G, Boyd STD, Huffmann J, Skinner DG (1990) The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144: 641

    PubMed  CAS  Google Scholar 

  13. van der Meuden APM, Kurth K-H, Oosteriinck W, Debruyne FMJ, and Members of the EORTC Genito-Urinary Group (1992) Intravesical therapy with Adriamycin and 4-epirubicin for superficial bladder cancer: the experiene of the EORTC GU Gruop. Cancer Chemother Pharmacol 30 (Suppl): 95–98

    Article  Google Scholar 

  14. Miller LS (1977) Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39: 973

    Article  PubMed  CAS  Google Scholar 

  15. Nijima T, Koiso K, Akagza H (1983) Randomized clinical trial on chemoprophylaxis of recurrences in cases of superficial bladder cancer. Cancer Chemother Pharmacol 11: 79

    Article  Google Scholar 

  16. Roehrbom CG, Sagalowsky AJ, Peters PC (1991) Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder. J Urol 146: 36

    Google Scholar 

  17. RUTT (Registry for Urinary Tract Tumors: Harnwegstumorregister) (1985) Jahresbericht. Verh Dtsch Ges Urol 37: 665

    Google Scholar 

  18. Sternberg CN, Yagoda A, Scher HJ, Whitmore WF jr, Watson RC, Hollander PS, Morse MJ, Herr HW, Sogant PC, Fair WR (1986) Surgical staging and long term survival in patients with advanced transistional cell carcinoma ( TCC) of the urothelium treated with M-VAC. Proc Am Soc Clin Oncol 5: 390

    Google Scholar 

  19. Stoter G (1985) Chemotherapy for metastatic bladder carcinoma. J Urol 3: 110

    Google Scholar 

Download references

Authors
  1. T. Otto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Al Enzawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Rübben
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Otto, T., Enzawi, S.A., Rübben, H. (1993). Harnblasenkarzinom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10495-8_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56872-8

  • Online ISBN: 978-3-662-10495-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation